Skip to main content

Table 1 Listing of ICD-8 and ICD-10 codes used to ascertain key diagnoses

From: Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study

Diagnosis ICD-8 ICD-10
Invasive breast carcinomaa 174.00 to 174.02; 174.08; 174.09; C50.0 to C50.6; C50.8; C50.9
Congestive heart failure 427.09; 427.10; 427.11; 427.19; 428.99; 782.49 I50; I11.0; I13.0; I13.2
Atrial fibrillation/flutterb 427.93; 427.94 I48
Myocardial infarction 410 I21; I22; I23
Peripheral vascular disease 440; 441; 442; 443; 444; 445 I70; I71; I72; I73; I74; I77
Cerebrovascular disease 430 to 438 I60 to I69; G45; G46
Chronic pulmonary disease 490 to 493; 515 to 518 J40 to J47; J60 to J67; J68.4; J70.1; J70.3; J84.1; J92.0; J96.1; J98.2; J98.3
Mild liver disease 571; 573.01; 573.04 B18; K70.0 to K70.3; K70.9; K71; K73; K74; K76.0
Moderate to severe liver disease 070.00; 070.02; 070.04; 070.06; 070.08; 573.00; 456.00 to 456.09 B15.0; B16.0; B16.2; B19.0; K70.4; K72; K76.6; I85
Diabetes type 1 249.00; 249.06; 249.07; 249.09 E10.0, E10.1; E10.9
Diabetes type 2 250.00; 250.06; 250.07; 250.09 E11.0; E11.1; E11.9
Moderate to severe renal disease 403; 404; 580 to 583; 584; 590.09; 593.19; 753.10 to 753.19; 792 I12; I13; N00 to N05; N07; N11; N14; N17 to N19; Q61
Diabetes with end organ damage (types 1 and 2) 249.01 to 249.05; 249.08; 250.01 to 250.05; 250.08 E10.2 to E10.8; E11.2 to E11.8
Solid tumor 140 to 194 C00 to C75
Lymphoma 200 to 203; 275.59 C81 to C85; C88; C90; C96
  1. aThe ICD codes for invasive breast carcinoma do not capture in situ tumors (for example, intraductal carcinoma); bICD-8 contained separate codes for atrial fibrillation (427.93) and flutter (427.94). These two diagnoses were combined into a single code in ICD-10 (I48).
  2. ICD, International Classification of Disease.